Betalin Therapeutics is developing the next generation of insulin-producing cell transplantation providing a solution for insulin-dependent diabetic people using tissue engineering.

Betalin developed a unique  micro organ scaffold that uses natural de-cellularized ECM, derived from natural tissue, to support the long term function of  β-cells.